Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$16.14 - $21.86 $8.85 Million - $12 Million
-548,455 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$19.03 - $41.33 $29,401 - $63,854
-1,545 Reduced 0.28%
548,455 $12.6 Million
Q2 2021

Aug 16, 2021

BUY
$18.0 - $37.42 $9.9 Million - $20.6 Million
550,000 New
550,000 $20.1 Million

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.09B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Alkeon Capital Management LLC Portfolio

Follow Alkeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.